Cargando…
Chimera and Tandem-Repeat Type Galectins: The New Targets for Cancer Immunotherapy
In humans, a total of 12 galectins have been identified. Their intracellular and extracellular biological functions are explored and discussed in this review. These galectins play important roles in controlling immune responses within the tumour microenvironment (TME) and the infiltration of immune...
Autores principales: | Ko, Frankie Chi Fat, Yan, Sheng, Lee, Ka Wai, Lam, Sze Kwan, Ho, James Chung Man |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296743/ https://www.ncbi.nlm.nih.gov/pubmed/37371482 http://dx.doi.org/10.3390/biom13060902 |
Ejemplares similares
-
Galectin-1 promotes hepatocellular carcinoma and the combined therapeutic effect of OTX008 galectin-1 inhibitor and sorafenib in tumor cells
por: Leung, Zoe, et al.
Publicado: (2019) -
Disturbance of the Warburg effect by dichloroacetate and niclosamide suppresses the growth of different sub-types of malignant pleural mesothelioma in vitro and in vivo
por: Lam, Sze-Kwan, et al.
Publicado: (2022) -
Nuclear-Targeted Deleted in Liver Cancer 1 (DLC1) Is Less Efficient in Exerting Its Tumor Suppressive Activity Both In Vitro and In Vivo
por: Chan, Lo-Kong, et al.
Publicado: (2011) -
Prototype and Chimera-Type Galectins in Placentas with Spontaneous and Recurrent Miscarriages
por: Unverdorben, Laura, et al.
Publicado: (2016) -
Cancer-Specific Delivery of Proteolysis-Targeting Chimeras (PROTACs) and Their Application to Cancer Immunotherapy
por: Moon, Yujeong, et al.
Publicado: (2023)